Enrocin Flavoured Tablets 150 mg
Enrocin Flavoured Tablets 150 mg
Authorised
- Enrofloxacin
Product identification
Medicine name:
Enrocin Flavoured Tablets 150 mg
Active substance:
- Enrofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Meat and offalno withdrawal periodNot applicable.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Lidding material: Plain 25-micron hard tempered Al foil coated with 7 GSM heat sealable lacquer Base foil & Forming foil: Multilayer cold form film (25-micron OPA/ 45-micron soft tempered Aluminum Foil/ 60-micron PVC film). 100 tablets.
- Lidding material: Plain 25-micron hard tempered Al foil coated with 7 GSM heat sealable lacquer Base foil & Forming foil: Multilayer cold form film (25-micron OPA/ 45-micron soft tempered Aluminum Foil/ 60-micron PVC film). 50 tablets.
- Lidding material: Plain 25-micron hard tempered Al foil coated with 7 GSM heat sealable lacquer Base foil & Forming foil: Multilayer cold form film (25-micron OPA/ 45-micron soft tempered Aluminum Foil/ 60-micron PVC film). 30 tablets.
- Lidding material: Plain 25-micron hard tempered Al foil coated with 7 GSM heat sealable lacquer Base foil & Forming foil: Multilayer cold form film (25-micron OPA/ 45-micron soft tempered Aluminum Foil/ 60-micron PVC film). 20 tablets.
- Lidding material: Plain 25-micron hard tempered Al foil coated with 7 GSM heat sealable lacquer Base foil & Forming foil: Multilayer cold form film (25-micron OPA/ 45-micron soft tempered Aluminum Foil/ 60-micron PVC film). 10 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic (abridged application) - art 13(1)
Marketing authorisation holder:
- Felix Pharmaceuticals Private Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Wasdell Europe Limited
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V661940
Date of authorisation status change:
Reference member state:
-
Portugal
Procedure number:
- PT/V/0141/003
Concerned member states:
-
Belgium
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 14/03/2026
